Ann: Appendix 3B, page-2

I see this as a positive. The options are 40% above the last traded price, and when exercised will generate about $90k in cash. But this cash inflow is not the point. The scientific advisory board do not get any benefit at all until the share price reaches 3c. They then effectively get $3k for every 0.1c. For the members to agree to this form of remuneration shows they seem to have great faith in outcomes. Will just let this unfold nicely and I look forward to the multiple results which are expected this month. Good luck to all.